Education
Peptide Half-Life & Research Terminology Explained
· SupplyPeptides Research Hub
Researchers encountering peptide catalogues often meet terms such as half-life, receptor affinity, agonist, and analogue. This glossary-style guide clarifies common terminology in a research context — without turning pharmacokinetic jargon into human dosing advice.
Half-life (research meaning)
In pharmacology and biochemistry papers, half-life usually describes how quickly a compound’s concentration declines in a defined system (plasma, buffer, cell media). Published half-lives are study-specific: they depend on species, route, assay, and formulation. A catalogue peptide’s “research half-life” in one paper is not a recommended human schedule.
Related terms you will see
- Agonist / antagonist — activates or blocks a receptor in experimental systems.
- Analogue — a modified sequence designed to alter stability or receptor selectivity versus a native peptide.
- Lyophilised — freeze-dried solid form common in research vials.
- Purity (HPLC) — chromatographic estimate of main-peak area; see our COA guide.
- Identity (MS) — mass spectrometry confirmation that the main species matches the expected mass.
How to read literature carefully
- Note the model (cell, animal, in vitro assay).
- Record units exactly as published.
- Prefer primary sources (PubMed) over marketing blogs.
- Never convert animal PK data into human-use protocols from a supplier page.
Related reading
Frequently asked questions
Does published half-life equal a human dose schedule?
No. Half-life figures in papers are study-specific and must not be converted into human dosing instructions from a supplier guide.